These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6362874)

  • 1. Therapeutic activity of mitoxantrone and ametantrone against murine tumors.
    Schabel FM; Corbett TH; Griswold DP; Laster WR; Trader MW
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():13-21. PubMed ID: 6362874
    [No Abstract]   [Full Text] [Related]  

  • 2. Overadditive synergism between the intercalators mitoxantrone and lucanthone in advanced L 12010 and P 388 leukemia.
    Osswald H; Youssef M
    J Cancer Res Clin Oncol; 1986; 111(2):137-40. PubMed ID: 2939092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitoxantrone (novantrone): a review of experimental and early clinical studies.
    Smith IE
    Cancer Treat Rev; 1983 Jun; 10(2):103-15. PubMed ID: 6347376
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequential studies on the role of mitoxantrone in the treatment of acute leukaemia.
    Prentice HG; Robbins G; Ma DD; Ho AD
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():57-63. PubMed ID: 6362878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone in acute lymphoblastic leukemia.
    Paciucci PA; Ohnuma T; Cuttner J; Silver RT; Holland JF
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():65-8. PubMed ID: 6581869
    [No Abstract]   [Full Text] [Related]  

  • 6. Mitoxantrone--a critique.
    Holland JF
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():77-9. PubMed ID: 6661738
    [No Abstract]   [Full Text] [Related]  

  • 7. Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancer.
    Smith IE; Stuart-Harris R; Pavlidis N; Bozek T
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():37-40. PubMed ID: 6661733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoxantrone versus doxorubicin in advanced breast cancer: a randomized cross-over trial.
    Neidhart JA; Gochnour D; Roach RW; Steinberg JA; Young D
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():41-6. PubMed ID: 6362877
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of mitoxantrone.
    White RJ; Durr FE
    Invest New Drugs; 1985; 3(2):85-93. PubMed ID: 2410393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics.
    Fujimoto S; Ogawa M
    Cancer Chemother Pharmacol; 1982; 8(2):157-62. PubMed ID: 7105379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors.
    Leopold WR; Nelson JM; Plowman J; Jackson RC
    Cancer Res; 1985 Nov; 45(11 Pt 1):5532-9. PubMed ID: 4053027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone as first line cytotoxic therapy in advanced breast cancer: preliminary results of a phase II study.
    Mouridsen HT; Rose C; Nooy MA; van Oosterom AT
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():47-52. PubMed ID: 6661734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic and biochemical effects of mitoxantrone.
    Durr FE
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):3-10. PubMed ID: 6484579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoxantrone.
    Nathanson L
    Cancer Treat Rev; 1984 Dec; 11(4):289-93. PubMed ID: 6534511
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness of nitrosomethylurea derivatives in the combined chemotherapy of experimental tumors].
    Krutova TV; Ostrovskaia LA
    Eksp Onkol; 1986; 8(5):47-50. PubMed ID: 3780511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Copper (II) glycinate-L-serinate--a representative of a new class of antitumor preparations].
    Treshchalina EM; Konovalova AL; Presnov MA
    Vestn Akad Med Nauk SSSR; 1986; (5):51-6. PubMed ID: 3727785
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of a human tumor cloning system to evaluate analogs of methotrexate and mitoxantrone.
    Lathan B; Von Hoff DD; Elslager E
    Cancer Treat Rep; 1984 May; 68(5):733-8. PubMed ID: 6233003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological evaluation of mitoxantrone dihydrochloride synthesized by a new method. II. Comparison of Now 85/34 and Novantrone (Lederle) acute toxicity and antitumor activity.
    Matuszyk J; Kuśnierczyk H; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):89-99. PubMed ID: 2619513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of the binding of mitoxantrone, ametantrone and analogues to DNA: relationship with binding mode and anti-tumour activity.
    Denny WA; Wakelin LP
    Anticancer Drug Des; 1990 May; 5(2):189-200. PubMed ID: 2357264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents.
    Corbett TH; Roberts BJ; Trader MW; Laster WR; Griswold DP; Schabel FM
    Cancer Treat Rep; 1982 May; 66(5):1187-200. PubMed ID: 7083221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.